1. Home
  2. WBX vs VYGR Comparison

WBX vs VYGR Comparison

Compare WBX & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WBX
  • VYGR
  • Stock Information
  • Founded
  • WBX 2015
  • VYGR 2013
  • Country
  • WBX Spain
  • VYGR United States
  • Employees
  • WBX N/A
  • VYGR N/A
  • Industry
  • WBX Industrial Specialties
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WBX Consumer Discretionary
  • VYGR Health Care
  • Exchange
  • WBX Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • WBX 102.7M
  • VYGR 164.3M
  • IPO Year
  • WBX N/A
  • VYGR 2015
  • Fundamental
  • Price
  • WBX $6.00
  • VYGR $3.20
  • Analyst Decision
  • WBX Buy
  • VYGR Strong Buy
  • Analyst Count
  • WBX 3
  • VYGR 8
  • Target Price
  • WBX $0.72
  • VYGR $14.33
  • AVG Volume (30 Days)
  • WBX 26.4K
  • VYGR 715.4K
  • Earning Date
  • WBX 07-31-2025
  • VYGR 08-05-2025
  • Dividend Yield
  • WBX N/A
  • VYGR N/A
  • EPS Growth
  • WBX N/A
  • VYGR N/A
  • EPS
  • WBX N/A
  • VYGR N/A
  • Revenue
  • WBX $171,352,140.00
  • VYGR $66,958,000.00
  • Revenue This Year
  • WBX N/A
  • VYGR N/A
  • Revenue Next Year
  • WBX $44.10
  • VYGR $78.88
  • P/E Ratio
  • WBX N/A
  • VYGR N/A
  • Revenue Growth
  • WBX 3.75
  • VYGR N/A
  • 52 Week Low
  • WBX $4.60
  • VYGR $2.65
  • 52 Week High
  • WBX $32.80
  • VYGR $9.55
  • Technical
  • Relative Strength Index (RSI)
  • WBX 36.26
  • VYGR 51.88
  • Support Level
  • WBX $6.10
  • VYGR $2.83
  • Resistance Level
  • WBX $6.36
  • VYGR $3.43
  • Average True Range (ATR)
  • WBX 0.67
  • VYGR 0.19
  • MACD
  • WBX -0.06
  • VYGR 0.01
  • Stochastic Oscillator
  • WBX 42.41
  • VYGR 55.22

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: